Stephen Bawden1,2, Scott Willis3, Aron Sherry3, Penny Gowland2, James King3, and Guruprasad P Aithal1
1NIHR Nottingham Biomedical Research Centre, University of Nottingham, Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, United Kingdom, 2Sir Peter Mansfield Imaging Centre, University of Nottingham, Nottingham, United Kingdom, 3School of Sport, Exercise and Health Sciences, Loughborough University, Loughborough, United Kingdom
Synopsis
1H MRS offers unique insights into hepatic lipid
composition. In this study, NAFLD patients with and without Type 2 Diabetes were scanned and hepatic lipid composition indices measured. Diabetic patients then underwent a randomized controlled trial to investigate the effectiveness of 6 weeks moderate exercise vs control. Lipid composition indices were similar to previous studies in obesity, and show no differences in diabetic v non-diabetic groups. The intervention also shows no change in hepatic fat fraction or lipid composition.
INTRODUCTION
Ectopic lipid deposition in the liver leads to several poor
health outcomes, and non-alcoholic fatty liver disease (NAFLD) is becoming an
increasing global health burden along with other related metabolic disorders [1].
Whilst most research in this field has focused on the quantity of lipid
accumulation, recent studies indicate that lipid composition also plays a key
role [2].
High resolution 1H MRS can be used to determine fat fractions within
the liver, and also to evaluate indices of lipid composition and therefore
provides a unique non-invasive method of evaluating the impact of lipid quality in these conditions [3].
The aim of this study was to compare lipid composition in NAFLD patients with
and without Type 2 diabetes, and to evaluate the impact of regular moderate
intensity exercise on these outcomes. METHODS
This study involved a cross sectional
comparison of Type 2 diabetic (NAFLD-D) vs non-diabetic (NAFLD-ND) patients and a subsequent
randomized control trial investigating the effects of regular moderate
intensity exercise in NAFLD-D. The study had local ethics approval and participants
were recruited from GP practices and general advertising.
Following an
overnight fast, participants were scanned for hepatic fat fraction using 1H
MRS and measurements of average blood glucose (HbA1c) and peak
oxygen uptake were taken.
NAFLD-D participants were then randomized
into either 6-weeks of exercise intervention (EX) or no intervention (CON). EX
participants completed 4 exercise sessions per week, 3 of which were supervised
by the research team. CON participants were asked to maintain their habitual
lifestyle. At the end of 6 weeks all participants returned for post-intervention
assessments (48 – 72 hours after final exercise session).
During test days participants were scanned on a Philips 3T Ingenia system. STEAM localised 1H MRS was acquired from a 20x20x20mm voxel in the
lower right lobe of the liver. Spectra were acquired in a single breath hold (TR =
2000 ms, TE = 15, 30, 45 and 80 ms, 2 averages per spectra), with and without water
suppression. To determine lipid composition, a high sensitivity 1H
MRS was acquired over 6 breath holds (TR = 2000 ms, 5 averages per breathhold,
30 averages in total in total).
In-house software was written in Matlab to auto phase correct and
frequency align spectra before averaging at each echo time. Peak amplitudes
were fitted for each TE using prior knowledge [4]
and the lscurvefit function (tolerances set according to [4]) and peak areas fitted to a monoexponential decay for water and fat T2. The
final fat fraction was calculated as T2 corrected fat/(fat + water). The short
TE multi-average data was used to identify individual lipid peaks and calculate
lipid composition indices.
Saturated fat indices (SI), Unsaturated fat indices (UI) and
Poly-Unsaturated fat indces (PUI) were calculated as previously described [3].
In addition, a short-chain fatty acid index (SCI) was developed by taking the
ratio of signal from end (methyl) to mid chain hydrogens whilst also considering the number
of carbons associated with each hydrogen as follows: [1/3 Methyl] / [1/3 Methyl
+ 1/2 (Methylene + β-Carboxyl
+ α-Olenfinic) + α-Carboxyl + Diacyl].RESULTS
Any subjects with
liver lipid values (PDFF) below 5.5% were excluded.
16 NAFLD-ND and 9 NAFLD-ND have been
recruited and completed a baseline scan so far (table 1). Acquired spectra has shown good
SNR with high spectral resolution, allowing for good peak fitting of individual fat
peaks (Figure 1). PDFF was 16 ± 6 % and 14 ± 1 % for NAFLD-ND and NAFLD-D groups respectively.
There are no significant differences between patient groups in SI (NAFLD-ND
= 0.9 ± 0.04; NAFLD-D = 0.9 ± 0.05), UI (NAFLD-ND = 0.14 ± 0.04; NAFLD-D = 0.13
± 0.05), PUI (NAFLD-ND = 0.03 ± 0.02; NAFLD-D = 0.03 ± 0.02) or SCI (NAFLD-ND =
0.10 ± 0.04; NAFLD-D = 0.08 ± 0.04) as shown in figure 2.
8 NAFLD-D participants have completed the 6 week intervention
period so far. Interim (blinded) analysis shows that PDFF values have
remained constant in both interventions (Group I: Visit 1 = 14 ± 2 %, Visit 2 =
14 ± 5 %; Group II: Visit 1 = 14 ± 3 %, Visit 2 = 14 ± 4 %). Similarly, there
are no changes in SI, UI, PUI or SCI between visit 1 and visit 2 in either
group.DISCUSSION
1H MRS
offers a unique insight into lipid composition and is more sensitive to fat
fraction than other imaging techniques (e.g. Dixon imaging). Lipid composition
indices from this study are similar to those found in obese subjects with and
without NAFLD from previous studies [3],
however there are no significant differences between NAFLD patients with and without Type 2 diabetes thus far, nor any effect of moderate exercise intervention in Type 2 diabetics (between
group effects). Studies in this area are still novel and exploratory and
further work should be done to establish the relevance of lipid composition in
other fat stores for varying conditions and interventions.Acknowledgements
We are grateful to Diabetes UK for funding this studyReferences
1. Perumpail, B.J., et al., Clinical epidemiology and disease burden of
nonalcoholic fatty liver disease. World Journal of Gastroenterology, 2017. 23(47): p. 8263-8276.
2. Erickson, M.L.,
et al., Non-invasive assessment of
hepatic lipid subspecies matched with non-alcoholic fatty liver disease
phenotype. Nutrition Metabolism and Cardiovascular Diseases, 2019. 29(11): p. 1197-1204.
3. Johnson, N.A.,
et al., Noninvasive assessment of hepatic
lipid composition: Advancing understanding and management of fatty liver
disorders. Hepatology, 2008. 47(5):
p. 1513-1523.
4. Hamilton, G., et
al., In vivo characterization of the
liver fat H-1 MR spectrum. Nmr in Biomedicine, 2011. 24(7): p. 784-790.